We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fusion Antibodies Plc | LSE:FAB | London | Ordinary Share | GB00BDQZGK16 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -1.47% | 3.35 | 3.30 | 3.40 | 3.40 | 3.35 | 3.40 | 1,029,509 | 09:00:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.9M | -2.6M | -0.0437 | -0.77 | 1.99M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/1/2018 18:39 | going to 50p secondary placing coming | lucicavi | |
05/1/2018 14:45 | I'm in at 166p .These should multibag in 1-3 years IMO . DYOR | fhasson | |
05/1/2018 11:12 | OXB hitting off ... excellent potential | fhasson | |
05/1/2018 10:05 | Thanks Bamboo , just annoyed I missed IPO price and trying to get good entry point. Strongly believe on my research this will do well in time . | fhasson | |
05/1/2018 08:35 | fhasson, there's very little to go on, on the daily chart that I use, due to the newness of the ipo. The gap however is of a type that I would expect to be filled relatively soon. | bamboo2 | |
04/1/2018 15:29 | Aim for 125 then? | fhasson | |
04/1/2018 13:06 | Chart shows a small area gap 18-19/12/2017 125-125.5 This could be a good entry point. | bamboo2 | |
04/1/2018 01:09 | Keen to add these to my portfolio. Aiming for further retrace though! Once Car-T hits off for immuno- oncology blockbuster cures there will be more potential growth for companies like FAB. Already in the bag for monoclonal antibody treatments on a global scale which is ever- increasing but the future is MAB and Car-T for chronic disease management and cancer treatment/ cure.Should be a multi- bagger . For LTH . | fhasson | |
27/12/2017 15:59 | cannot buy in any large numbers | falia | |
27/12/2017 15:53 | Beware falia pump and dump | dave4545 | |
27/12/2017 15:52 | cannot buy £2.50+ tomorrow | falia | |
27/12/2017 11:24 | rocket time | falia | |
27/12/2017 10:52 | The rise continues unabated though of course the stock is quite illiquid so this can work both ways.. | gersemi | |
23/12/2017 16:04 | Hoping for some retrace then I am in for 3- 5 years minimum. Holding heavy with OXB which I think will complement FAB when they start to hit off. Yuletide greetings to our homegrown unicorn potential scientists at Queens | fhasson | |
20/12/2017 20:52 | Interesting you should mention Horizon gersemi. Horizon were one of the peer group comparitors used in Allenby's Pre-IPO research note (see below) | timbo003 | |
20/12/2017 20:29 | I've been watching it and can't believe it's doubled since its flotation. Remarkable. Another Horizon Discovery? | gersemi | |
20/12/2017 20:26 | Another rather excellent day, I find it surprising that no one else appears to be interesting in FAB given that they have increased by over 120% in just three days. | timbo003 | |
20/12/2017 09:23 | Future revenue/earnings estimates from The Allenby pre-IPO note (dated November 2017): | timbo003 | |
19/12/2017 19:48 | Thanks to Anna at Walbrook for steering me in the right direction regarding videos. Here's a link to a BRR media video of the IPO recorded at the LSE on Monday morning which includes a brief interview with Paul Kerr (CEO): | timbo003 | |
19/12/2017 10:10 | Another good day (so far), I have requested that ADVFN assign the correct name to the ticker (FAB) and I will find out from Walbrook whether there any any interviews or research notes now available: | timbo003 | |
18/12/2017 19:05 | Numbers aren't great from the last 6 months? | drmaccers | |
18/12/2017 12:56 | I picked up a few EIS qualifying shares in the IPO at 82p/share, there was a bit of scale back (circa 15%). Could these can emulate Bioventix after their AIM debut (subsequently multi-bagged)? | timbo003 | |
18/12/2017 12:49 | Off to a good start * First day of dealing today (Monday 18th December) * £5.5 million raised by the conditional placing of 6,707,317 new Ordinary Shares at a placing price of 82p * The new Ordinary Shares represent c. 30.4 per cent. of the enlarged share capital on Admission * Selling shareholders have sold 1,310,976 existing Ordinary Shares as part of the placing | timbo003 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions